July 2024 Issue

Watch for Resmetirom to Treat NASH

Resmetirom (Rezdiffra) will be the first med approved for treatment of nonalcoholic steatohepatitis (NASH) with fibrosis in adults...

GO TO FULL ISSUE

CE & Training

Female prescriber working on notebook computer with clipboard and pen by her side.

NEW REQUIRED COURSE: Substance Use Disorders and Pain Management: MATE Act Training

PODCAST CE: Pharmacotherapy for Anxiety and Depression

CE-IN-THE-LETTER: Prescriber Insights July 2024

LIVE CE: Precepting: Strategies for Helping Learners Succeed

GO TO CE & TRAINING ORGANIZER

Free Clinical Resources

Weight Loss Products

Pharmacotherapy of Anxiety Disorders in Adults

Drugs for Type 2 Diabetes

GO TO ALL CLINICAL RESOURCES

What is Prescriber Insights: PA?

Prescriber Insights: PA is the fastest, most trustworthy way for PAs to find out how drug therapy changes should fit into your practice. It's unbiased, evidence-based, and 100% free from financial support of the pharma industry. Learn more >


NetCE, A TRC Healthcare Brand, All Access: PA. Easily Meet State Mandates. Get unlimited access to 1,000+ hours of CME that meets state mandates exclusively for PAs. Learn More

Unlock More

Prescriber Insights: PA is one of many medication advisory and CE solutions from TRC Healthcare for physician assistants. Learn more about:


Group Purchases & Pricing

Prescriber Insights: PA is eligible for bulk discounts. Easy for admins to manage access, easy for staff to track CME requirements. Bundle with more evidence-based tools and save. Request information